Home > DARE Reviews > Impact of estimated GFR reporting on...

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.

Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet]. York (UK): Centre for Reviews and Dissemination (UK); 1995-.

Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet].

Impact of estimated GFR reporting on patients, clinicians, and health-care systems: a systematic review

Review published: 2011.

Bibliographic details: Kagoma YK, Weir MA, Iansavichus AV, Hemmelgarn BR, Akbari A, Patel UD, Garg AX, Jain AK.  Impact of estimated GFR reporting on patients, clinicians, and health-care systems: a systematic review. American Journal of Kidney Diseases 2011; 57(4): 592-601. [PubMed: 21146269]

Abstract

BACKGROUND: Many laboratories now report estimated glomerular filtration rate (eGFR) when a serum creatinine measurement is ordered. A summary of the impact of eGFR reporting in health care systems around the world for which it has been adopted is lacking.

STUDY DESIGN: Systematic review of MEDLINE, EMBASE, other major databases, and conference proceedings of major nephrology meetings.

SETTING & POPULATION: Any health care system in which eGFR reporting was introduced.

SELECTION CRITERIA FOR STUDIES: Published studies or abstracts reporting patient, clinician, or health system outcomes of eGFR reporting.

INTERVENTION: eGFR reporting.

OUTCOMES: Volume of referrals or consults seen by nephrologists, changes in characteristics of patients who were seen, and prescription rates of kidney-related medications.

RESULTS: 22 studies (10 full text and 12 conference abstracts) were identified in 2004-2010 from 5 countries. Nephrologist referrals and consultations increased after eGFR reporting, ranging from 13%-270%. The greatest increases in referrals were seen for the elderly, females, and those with stage 3 or higher chronic kidney disease (eGFR <60 mL/min/1.73 m(2)). Change in renin-angiotensin-aldosterone system-blocking drug use ranged from increases of 0%-6%.

LIMITATIONS: Studies were highly variable in definition of outcomes. Reports were not available for many health care systems in which eGFR reporting was implemented.

CONCLUSIONS: eGFR reporting has been associated with greater identification of patients with decreased kidney function in most health care systems that have reported its impact.

Copyright © 2011 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

CRD has determined that this article meets the DARE scientific quality criteria for a systematic review.

Copyright © 2014 University of York.

PMID: 21146269

PubMed Health Blog...

read all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...